Dr. Mercola's Censored Library (Private Membership)

Share this post
Ivermectin vs. Merck's New Antiviral, Molnupiravir
takecontrol.substack.com

Ivermectin vs. Merck's New Antiviral, Molnupiravir

Based on Merck's data, a comparison between molnupiravir and ivermectin yields interesting results. Consider other nonprescription strategies for prevention and early treatment.

Dr. Joseph Mercola
Oct 25, 2021
Comment
Share

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2022 Dr. Joseph Mercola
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing